TrialBMC cancer2004

Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme.

Xin-Lin Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.